Abiopharma

🔍 HOLLIHAN JOHN P III (Director)

Company: Armour Residential REIT, Inc. (ARR)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 1,900 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,141.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 760 shares of Common Stock at $16.32 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 21,381.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,900 shares of Phantom Stock (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,354.00 | transaction_form_type: 4 | Footnotes: F2, F1, F1

Footnotes:

• F1: On August 21, 2026, the reporting person elected to convert 1,140 shares out of 1,900 shares of vested phantom stock into 1,140 shares of ARMOUR common stock. The person elected to convert the remaining 760 shares of vested phantom stock into cash solely to pay income taxes on the vested stock. The 1,900 shares are part of, and relate to, phantom stock vesting over a five-year period, which was reported on a Form 4 filed by the reporting person on February 14, 2023, December 18, 2025 and May 21, 2026.
• F2: Each unit of phantom stock is the economic equivalent of one share of ARMOUR common stock.